Found 45 matching trials
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection PHASE3 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection PHASE3 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
Combination Therapy for Chronic Hepatitis C Infection PHASE2 Background:
\- GS-7977, GS-5885, GS-9669, and GS-9451 are new drugs for tr...
Show More Location
Unity Health Care, Inc./DC General
Learn More & Join Trial
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF PHASE2 People who are infected with Hepatitis C Virus (HCV) have a great chance of...
Show More Location
Ucsf Aids Crs (801)
Learn More & Join Trial
Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection PHASE2 This primary objectives of the study are to evaluate the safety, tolerabili...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection PHASE2 This study will evaluate the antiviral efficacy, safety, and tolerability o...
Show More Location
Multiple Locations
Learn More & Join Trial
Transplanting Hepatitis C Lungs Into Negative Lung Recipients PHASE1 This study is being conducted to determine safety and effectiveness of tran...
Show More Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Utilization of Hepatitis C Positive Kidneys in Negative Recipients PHASE2 To evaluate the safety and feasibility of transplanting kidneys from Hepati...
Show More Learn More & Join Trial
Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs PHASE4 The study aimed to present our experience in treating recurrent HCV genotyp...
Show More Location
Multiple Locations
Learn More & Join Trial